| Financial Year |
March 31 2023 |
| Monetary Funds |
972,236,868.64 |
| Held-for-trading Financial Assets |
1,150,288,062.44 |
| Notes Receivable |
7,361,338.78 |
| Accounts Receivable |
950,582,461.76 |
| Advances to Suppliers |
18,138,220.09 |
| Other Receivables |
34,215,504.15 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
521,728,720.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
30,649,844.22 |
| Total Current Assets |
3,710,410,606.35 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,391,819.73 |
| Investment Properties |
129,048,978.05 |
| Fixed Assetes |
2,255,616,484.78 |
| Under-construction Projects |
348,209,601.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
223,224,981.35 |
| R&D expenses |
-- |
| Goodwill |
252,323,816.14 |
| Long-Term Deferred and Prepaid Expenses |
121,635,276.03 |
| Deferred Income Tax Assets |
190,293,351.78 |
| Other Non-Current Assets |
68,572,868.03 |
| Sub-Total of Non-Current Assets |
3,777,199,705.15 |
| Total Assets |
7,487,610,311.50 |
| Short-Term Loans |
282,257,000.49 |
| Trading Financial liabilities |
350,649.00 |
| Notes Payable |
147,849,182.03 |
| Accounts Payable |
666,320,806.64 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,702,097.42 |
| Taxes Payable |
52,362,604.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
68,138,178.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,626,715.54 |
| Other Current Liabilities |
19,808,658.29 |
| Sub-Total of Current Liabilities |
1,339,776,449.13 |
| Long-term Loans |
47,894,108.91 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
113,020,885.73 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
267,448,615.91 |
| Total Liabilities |
1,607,225,065.04 |
| Paid-In Capital(Or Share Stock) |
683,244,203.00 |
| Capital Surplus |
3,558,672,279.97 |
| Surplus Reserve |
192,805,670.30 |
| LESS:Treasury Stock |
100,991,878.25 |
| Undistributed Profits |
1,534,487,831.30 |
| Minority Stockholder's Interest |
6,514,324.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,873,870,921.55 |
| Owner's Equity（Stockholder's Equity） |
5,880,385,246.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,487,610,311.50 |
